BRAF V600E mutations, for example, occur in about 8%–10% of colorectal cancer patients and are usually associated with a poorer prognosis and higher levels of aggressiveness (Bond and Whitehall, 2018; Grothey et al., 2021). This evidence concerns the gene BRAF and colorectal cancer.